title: Retiform purpura and digital gangrene secondary to antiphospholipid syndrome successfully treated with sildenafil.
authors.affiliation: Department of Dermatology, New York University School of Medicine, New York, NY 10016, USA.
authors.forename: Mercedes E
authors.initials: ME
authors.lastname: Gonzalez
authors.forename: Philip
authors.initials: P
authors.lastname: Kahn
authors.forename: Harper N
authors.initials: HN
authors.lastname: Price
authors.forename: Hideko
authors.initials: H
authors.lastname: Kamino
authors.forename: Julie V
authors.initials: JV
authors.lastname: Schaffer
mesh_terms: D000293:Adolescent; D016736:Antiphospholipid Syndrome / Q000150:complications*; D005260:Female; D005534:Foot Diseases / Q000188:drug therapy* / Q000209:etiology; D005734:Gangrene / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*; D011687:Purines / Q000627:therapeutic use; D011693:Purpura / Q000188:drug therapy* / Q000209:etiology; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000627:therapeutic use*; D014034:Toes / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D058986:Phosphodiesterase 5 Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate